Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Prepaid Assets (2016 - 2026)

Sunshine Biopharma filings provide 14 years of Prepaid Assets readings, the most recent being $105345.0 for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 90.7% to $105345.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $105345.0, a 90.7% decrease, with the full-year FY2025 number at $105345.0, down 90.7% from a year prior.
  • Prepaid Assets hit $105345.0 in Q4 2025 for Sunshine Biopharma, down from $441489.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.8 million in Q2 2024 to a low of $10993.0 in Q1 2021.
  • Median Prepaid Assets over the past 5 years was $129642.5 (2023), compared with a mean of $403696.6.
  • Biggest five-year swings in Prepaid Assets: soared 1859.2% in 2024 and later crashed 90.7% in 2025.
  • Sunshine Biopharma's Prepaid Assets stood at $29625.0 in 2021, then surged by 857.97% to $283799.0 in 2022, then rose by 9.44% to $310591.0 in 2023, then soared by 264.88% to $1.1 million in 2024, then crashed by 90.7% to $105345.0 in 2025.
  • The last three reported values for Prepaid Assets were $105345.0 (Q4 2025), $441489.0 (Q3 2025), and $939436.0 (Q2 2025) per Business Quant data.